Evidence map›Paper›PMID 39349444›Full record

ArticleCell death discovery2024

Characterization of regulated cancer cell death pathways induced by the different modalities of non-thermal plasma treatment.

Eline Biscop, Jana Baroen, Joey De Backer, Wim Vanden Berghe, Evelien Smits, Annemie Bogaerts, Abraham Lin

Abstract read
In one paragraph

Article in Cell death discovery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Eline BiscopPLASMANT, Department of Chemistry, University of Antwerp, Antwerp, Belgium. eline.biscop@uantwerpen.be.
Jana BaroenPLASMANT, Department of Chemistry, University of Antwerp, Antwerp, Belgium.ORCID http://orcid.org/0000-0002-8983-5893
Joey De BackerCell Death Signaling Lab, University of Antwerp, Antwerp, Belgium.
Wim Vanden BergheCell Death Signaling Lab, University of Antwerp, Antwerp, Belgium.
Evelien SmitsCenter for Oncological Research - Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.
Annemie BogaertsPLASMANT, Department of Chemistry, University of Antwerp, Antwerp, Belgium.ORCID http://orcid.org/0000-0001-9875-6460
Abraham LinPLASMANT, Department of Chemistry, University of Antwerp, Antwerp, Belgium. abraham.lin@uantwerpen.be.ORCID http://orcid.org/0000-0003-0097-3323

Funding

Fonds Wetenschappelijk Onderzoek (Research Foundation Flanders) 12S9221NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) G033020NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) G044420N
6 · The paper itself

Abstract

Non-thermal plasma (NTP) has shown promising anti-cancer effects, but there is still limited knowledge about the underlying cell death mechanisms induced by NTP and inherent differences between NTP treatment modalities. This study aimed to investigate four major regulated cell death (RCD) pathways, namely apoptosis, pyroptosis, necroptosis, and ferroptosis, in melanoma cancer cells following NTP treatment, and to provide an overview of molecular mechanistic differences between direct and indirect NTP treatment modalities. To discriminate which cell death pathways were triggered after treatment, specific inhibitors of apoptosis, pyroptosis, necroptosis, and ferroptosis were evaluated. RCD-specific molecular pathways were further investigated to validate the findings with inhibitors. Both direct and indirect NTP treatment increased caspase 3/7 and annexin V expression, indicative of apoptosis, as well as lipid peroxidation, characteristic of ferroptosis. Pyroptosis, on the other hand, was only induced by direct NTP treatment, evidenced by increased caspase 1 activity, whereas necroptosis was stimulated in a cell line-dependent manner. These findings highlight the molecular differences and implications of direct and indirect NTP treatment for cancer therapy. Altogether, activation of multiple cell death pathways offers advantages in minimizing treatment resistance and enhancing therapeutic efficacy, particularly in a combination setting. Understanding the mechanisms underlying NTP-induced RCD will enable the development of strategic combination therapies targeting multiple pathways to achieve cancer lethality.

Identifiers

PMID39349444
PMCPMC11442809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.